Biopharmia focuses on commercialising our technology for production of microalgae. One of our goals is to build a production plant in Norway based on our technology.
Biopharmia works closely with Professor Joel Cuello at the University of Arizona.
We have operated our technology in a plant in Arizona since 2010 and produced many hundreds of kilos of algae.
OUR HISTORY:
2005: Founder Roald Flo begins work on beta-glucans
2009: Company formed. Begins development work on Accordion and focus on microalgae
2011: Accordion patent submitted
2011: Supply of biomass to Norwegian feed company
2012: Supply of biomass to Norwegian omega 3 company
IFE Venture invests in Biopharmia and buys ca 10% of the company
2014: 2 follow-up patents submitted
2015: Study on establishment at Esval Miljøpark, supported by Regional Research Authority
Commencement of commercialisation
Signed Letter of Intent with leading Norwegian nutraceuticals manufacturer about supply of two types of
microalgae biomass
2016: Series A financing round to build algae production plant in Norway
Accordion receives a grant from EU's H2020 SME programme, phase 1 contract no. 744643 
OUR VISION:
Biopharmia is the foundation of a new sustainable industry built on microalgae. Our actions and our technology make a difference and we provide solutions to global challenges.
OUR PARTNERS:
Institute for Energy Technology University of Arizona, Tucson
THE TEAM:
| |
 |
 |
 |
| |
Joel Cuello |
Arne Råheim |
Roald Flo |
| |
Professor at the
University of Arizona
|
Retired executive VP
at IFE. Particular
interest and experience
in IP and nutrients
for large-scale algae
production
|
Founder and chairman |
Gå til toppen... 
